BLOG

GTM Is Not a Quick Fix – Why 90-Day Sales Schemes Keep Failing

Nov 13 2026

Quick answer: A 90-day sales scheme is a painkiller, not a cure. It numbs the symptom — sales jump while the scheme runs — then the pain returns the moment it ends. A market gets well the way a patient does: diagnosis, a consistent treatment plan, and regular follow-ups. That is why go-to-market needs an always-on field engine, not another quarterly push.
AnaxeeAbout Anaxee

40,000+ Digital Runners · 540 districts · 26 states · 11,000+ pincodes of reach

★ Winner, National Startup Award (Govt. of India)Tech-tracked field executionTrusted by 350+ brands

One doctor visit does not make you healthy. One 90-day GTM campaign does not win you the market. Both feel like action, and both fail for the same reason: you treated a long-term condition with a one-time fix.

You know the pattern. A scheme launches and the numbers jump — distributors load up, a few retailers stock, the dashboard looks healthy. Then, around day 90, the scheme ends and the symptoms come straight back. Sales flatten, the shelf cools, and the distributor quietly shifts attention to whoever is still showing up. That is not a marketing failure. It is what a painkiller always does.

Anaxee infographic: the 90-day quick fix (launch a scheme, sales spike for a quarter, then the market relapses - a painkiller that wears off) versus ongoing market care (diagnose, treat, follow up - a cure that compounds).
Two ways to treat a weak market — a 90-day painkiller, or ongoing care that compounds.

Why the 90-day quick fix always relapses

A scheme treats the symptom — slow sales — without touching the cause. The cause is usually a weak market system underneath: a distributor pushing competing brands, a beat that is not run consistently, retailers who do not yet trust you, deliveries that slip. A discount papers over all of that for a quarter. When the discount stops, nothing underneath has actually changed, so the market relapses to exactly where it was — minus the margin you just spent.

  • The spike is secondary, not real demand. Distributors stock up to claim the scheme; it looks like growth, but the stock has only moved one step down the pipe, not into consumers’ hands.
  • Retailers do not trust one-time visits. A rep who appears only when there is a scheme is a salesman; a rep who shows up every week is a relationship. Trust is built on the boring visits, not the loud ones.
  • Skipped discipline behaves like skipped medication. Miss the beat for a few weeks and the problem does not announce itself — it quietly returns, and you only notice when a competitor is on the shelf.

A scheme numbs the symptom and wears off. A market gets well the way a patient does — diagnosis, a steady treatment plan, and follow-ups that never really stop.

Treat the market like a patient, not a campaign

A good doctor does not hand you a strip of tablets and disappear. They diagnose before they prescribe, they set a plan you follow consistently, and they bring you back for follow-ups to see whether it is actually working. Go-to-market that lasts works exactly the same way:

  • Diagnose first. Map every shop in the market, profile the retailers, and find the real leaks — distributor gaps, credit issues, dead routes — before spending a rupee on a scheme.
  • Treat consistently. Run the beat every week, keep the promises, solve problems locally. The treatment is repetition, not intensity.
  • Follow up with real data. Check the market with ground-truth evidence — geo-tagged visits, retailer-level numbers — not a distributor’s word, so you catch a relapse early instead of at the next review.

The market doctor’s method

This is how managed GTM runs on the ground — a repeatable diagnosis-to-treatment loop, tracked end to end:

Step 1 · Diagnose

Market mapping

Discover and map every target shop in a district onto one dashboard — the full market, not just the distributor’s favourites.

Step 2 · Profile

Know Your Retailer

Profile each outlet with ground-truth detail — type, location, owner, stock — so decisions rest on real data, not guesswork.

Step 3 · Treat

Order taking & beat

Acquire outlets, promote the range and run the route consistently — every visit geo-tagged, time-stamped and verified.

The difference from a scheme is that none of this switches off at day 90. The platform and the 40,000+ Runner network already exist, so the market keeps getting treated — and keeps getting stronger — whether or not head office is watching.

AnaxeeProof — consistent field execution at scale
30,000retailers onboardedUdaanRead case study →25,000leads · 225 districtsEscortsRead case study →14,500shops coveredAPAR IndustriesRead case study →

On-ground across 540 districts, every visit geo-tagged and verified. See all case studies →

AnaxeeStop prescribing painkillers to your market.

Anaxee runs consistent, tech-tracked GTM across 540 districts — diagnosis to follow-up — and shows you the progress every week.

Book a meeting

Frequently asked questions

Why do sales schemes stop working after 90 days?
Because a scheme treats the symptom, not the cause. The discount lifts secondary sales while it runs, but the underlying market — distributor focus, retailer trust, beat discipline — is unchanged, so the numbers relapse the moment the scheme ends. Lasting growth comes from consistent execution, not a quarterly push.
Is a three-month GTM campaign enough to win a market?
No. A single district typically needs 60–90 days just to stabilise, 3–6 months to build retailer trust, and 6–12 months before growth is predictable. Three months is barely the diagnosis and the first course of treatment — not a cure. Plan GTM in quarters of consistent effort, not one campaign.
What should we do instead of running another scheme?
Diagnose before you prescribe: map the market, profile the retailers, and fix the real leaks — then run the beat consistently and verify execution with ground-truth data. A scheme can still be a useful booster, but only on top of a healthy system, never as a substitute for one. See why GTM fails and managed GTM.
How is this different from hiring a field team or running a campaign?
A raw field team gives you effort; a campaign gives you a burst. Managed GTM gives you a tracked treatment programme — diagnosis, consistent execution, a live dashboard and weekly course-correction — on a pay-per-task model with no standing payroll.
How long before managed GTM shows results?
Expect noise, not numbers, in the first 60–90 days while the market stabilises; more regular orders and honest data by 3–6 months; predictable, forecastable growth by 6–12 months; and a compounding lead after a year of consistent execution.
Keep reading
GTM is a fitness journeyGTM is a fitness journey →Why GTM failsWhy GTM fails →Managed GTMManaged GTM: you need a coach →
Views: 6
Written by the founder

Govind Agrawal is the Founder & CEO of Anaxee Digital Runners — India’s Reach Engine. He writes on last-mile reach across Bharat, go-to-market, field data and climate-tech execution.

More from Govind Agrawal → govindagrawal.com

Anaxee Digital Runners